Will Holt reviews “Leaves of Grass,” Edward Weston photography at the Museum of Fine Arts (MFA) Boston.
Tag: Boston
Brown and Warren keep their promise: no third party ads
The Brown-Warren pledge represents a model for the rest of the country, one that should be strictly adhered to in an election season that promises to be rife with a slew of misinformation and even outright lies.
University reputation, rankings & reality
University communications and institutional research experts expressed doubt about the accuracy and usefulness of most college reputation and ranking systems.
Massachusetts to collaborate with innovation regions in Medicon Valley, Skandinavia, and Catalonia, in Spain
Massachusetts governor signs collaboration agreements with Medicon Valley in Denmark and Sweden, and with Catalonia, in Spain.
Fareed Zakaria: Will US maintain its innovation lead in new global landscape?
Speaking at the 2012 BIO International Convention, CNN’ s Fareed Zakaria said that while he is optimistic about the future, it is by no means clear who will be the winners and the losers in a changing global landscape.
Companies Receive $1.3 M in MA-Israeli Collaboration Grants
Four Boston area Israeli collaborations receive $1.3 in funding for innovative medical and energy projects under new MA/Israel partnership.
AC Immune/Genentech to Partner on R&D for Alzheimer’s Antibody; $418M Agree’t
AC Immune has entered into a second exclusive worldwide license agreement and research collaboration with Genentech,of the Roche Group, for the research, development and commercialization of AC Immune’s anti-Tau antibodies for the potential treatment of Alzheimer’s disease and other neurodegenerative diseases. The agreement is valued at $400M.
Pasteur Institute Spin-out Ariana Pharma Opens Cambridge Office; Analytics Tech to Streamline Clinical Trials
Anita Harris of New Cambridge Observer writes that Ariana Pharma opens Ariana Data Intelligence, Inc., in Cambridge. Ariana offers “KEM” non-statistical analysis technology to streamline and to cut financial risk of clinical trials.